| Product NDC: | 0472-0013 |
| Proprietary Name: | Griseofulviin (microsize) |
| Non Proprietary Name: | Griseofulvin (microsize) |
| Active Ingredient(s): | 125 mg/5mL & nbsp; Griseofulvin (microsize) |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0472-0013 |
| Labeler Name: | Actavis Mid Atlantic LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065394 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070726 |
| Package NDC: | 0472-0013-04 |
| Package Description: | 120 mL in 1 BOTTLE (0472-0013-04) |
| NDC Code | 0472-0013-04 |
| Proprietary Name | Griseofulviin (microsize) |
| Package Description | 120 mL in 1 BOTTLE (0472-0013-04) |
| Product NDC | 0472-0013 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Griseofulvin (microsize) |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20070726 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Mid Atlantic LLC |
| Substance Name | GRISEOFULVIN |
| Strength Number | 125 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Decreased Mitosis [PE],Microtubule Inhibition [PE],Tubulin Inhibiting Agent [EPC] |